Advanced Neuromodulation Systems Inc. Receives European Approval For Rapid Programmer(R) 3.0 Clinician Programming Platform

Published: Jan 17, 2007

PLANO, Texas--(BUSINESS WIRE)--Advanced Neuromodulation Systems (ANS), the neuromodulation business of St. Jude Medical, Inc. (NYSE:STJ), today announced European CE Mark approval for its newest clinician programming platform, Rapid Programmer 3.0 for spinal cord stimulation (SCS), an advanced therapy for managing chronic pain.

Back to news